Cardiovascular Pharmacology - Hypertension and Heart Failure

Join our Continuing Education (CE) course for Nurses and Nurse Practitioners (NPs) on Cardiovascular Pharmacology: Hypertension and Heart Failure to develop a comprehensive understanding of pharmacological management strategies for these prevalent cardiovascular conditions. This course provides in-depth knowledge of antihypertensive agents, including ACE inhibitors, ARBs, beta-blockers, calcium channel blockers, and diuretics, as well as heart failure medications such as aldosterone antagonists, ARNIs, and HCN channel blockers. Participants will learn about the physiological mechanisms these drugs target, their indications, contraindications, and potential adverse effects. Emphasis is placed on patient-specific considerations and clinical decision-making when prescribing these medications, particularly in patients with comorbid hypertension and heart failure. The course also explores the use of combination therapies for optimized blood pressure control and support of heart function. Learners will gain skills in safely administering medications, managing drug interactions, and adjusting treatment based on individual patient profiles. Through evidence-based insights, this course equips healthcare professionals to deliver personalized, effective, and safe pharmacological interventions for cardiovascular patients, ultimately improving clinical outcomes and quality of care.

Educational Objectives

• Describe the pharmacological goals of managing hypertension and the physiological mechanisms targeted by antihypertensive medications.
• Explain the mechanisms of action, indications, and potential adverse effects of ACE inhibitors, ARBs, beta-blockers, calcium channel blockers, diuretics, aldosterone antagonists, ARNIs, and HCN channel blockers.
• Discuss clinical considerations and safety precautions in prescribing cardiovascular medications, especially for patients with coexisting heart failure.
• Analyze the roles of combination pharmacotherapy in managing hypertension in patients with heart failure.
• Evaluate patient-specific factors influencing drug selection and treatment adjustments for hypertensive patients with heart failure.

Who Should Do This Course

This course is specifically designed for Registered Nurses (RNs) and Nurse Practitioners (NPs) seeking to fulfill state-mandated continuing education requirements in pharmacology. It is especially relevant for nurses practicing in states requiring continuing education in pharmacology, advanced pharmacology, or pharmacotherapeutics for license renewal, including:

• Advanced Pharmacology – Ohio, Alaska
• Pharmacotherapeutics – Hawaii, Louisiana, Oklahoma, West Virginia, Connecticut, Arkansas, Illinois, Nebraska, South Carolina, Texas, Washington, Wisconsin
• Pharmacology – Alabama, Indiana
• Pharmacology Education – Hawaii, Idaho, Kentucky, New Hampshire, North Dakota, Rhode Island, New Mexico, District of Columbia, Virginia, Montana

Whether you're working in primary care, cardiology, or general practice, this course provides essential insights to enhance your competency in cardiovascular pharmacotherapy.

Did You Know?

• Hypertension affects nearly half of the U.S. adult population—about 120 million people—as reported by the CDC in 2023.
• Heart failure contributes to approximately 6.7 million hospitalizations annually in the United States.
• Beta-blockers and ACE inhibitors remain the cornerstone therapies for both hypertension and heart failure, improving both survival and quality of life.
• The American Heart Association recommends combination therapy for patients who are more than 20 mmHg above their target blood pressure.
• Proper management of hypertension can reduce the risk of stroke by 35–40% and the risk of myocardial infarction by 20–25% (JNC 8 Guidelines).